BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31557324)

  • 1. Eliminating cervical cancer: Promising developments in primary prevention.
    Ficht AL; Lapidos-Salaiz I; Phelps BR
    Cancer; 2020 Jan; 126(2):242-246. PubMed ID: 31557324
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical Awareness Rabbit (CARA).
    Zhou F; Marcus A
    Int J Surg Pathol; 2021 May; 29(3):300. PubMed ID: 32423263
    [No Abstract]   [Full Text] [Related]  

  • 3. HPV-related cancer prevention through coalition building.
    Lind E; Welch K; Perkins RB
    Hum Vaccin Immunother; 2017 Oct; 13(10):2300-2306. PubMed ID: 28901813
    [No Abstract]   [Full Text] [Related]  

  • 4. The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.
    Martín-Merino E; Llorente-García A; Castillo Cano B; Montero Corominas D; Huerta-Álvarez C
    Pharmaceut Med; 2019 Dec; 33(6):519-530. PubMed ID: 31933243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention.
    Nowakowski A; Arbyn M; Turkot MH; Wieszczy P; Miłosz K; Kamiński MF; Didkowska J; Bidziński M; Olszewski W; Wielgoś M; Krzakowski M; Kuchar E; Walewski J
    Eur J Cancer Prev; 2020 Mar; 29(2):157-164. PubMed ID: 31517672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HPV vaccine controversy.
    Intlekofer KA; Cunningham MJ; Caplan AL
    Virtual Mentor; 2012 Jan; 14(1):39-49. PubMed ID: 23116916
    [No Abstract]   [Full Text] [Related]  

  • 7. Who should get the HPV vaccine?
    Pichichero ME
    J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808
    [No Abstract]   [Full Text] [Related]  

  • 8. Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India.
    Kaur P; Mehrotra R; Rengaswamy S; Kaur T; Hariprasad R; Mehendale SM; Rajaraman P; Rath GK; Bhatla N; Krishnan S; Nayyar A; Swaminathan S
    Indian J Med Res; 2017 Aug; 146(2):153-157. PubMed ID: 29265015
    [No Abstract]   [Full Text] [Related]  

  • 9. Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine.
    Brotherton JM; Fairley CK; Garland SM; Gertig D; Saville M
    Sex Health; 2010 Sep; 7(3):397-8. PubMed ID: 21058499
    [No Abstract]   [Full Text] [Related]  

  • 10. Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.
    Setiawan D; Andrijono ; Hadinegoro SR; Meyta H; Sitohang RV; Tandy G; Perwitasari DA; Postma MJ
    PLoS One; 2020; 15(3):e0230359. PubMed ID: 32203527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

  • 12. Global elimination of cervical cancer is achievable-with commitment.
    The Lancet Oncology
    Lancet Oncol; 2019 Nov; 20(11):1467. PubMed ID: 31674306
    [No Abstract]   [Full Text] [Related]  

  • 13. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 14. Low rates of free human papillomavirus vaccine uptake among young women.
    Moore GR; Crosby RA; Young A; Charnigo R
    Sex Health; 2010 Sep; 7(3):287-90. PubMed ID: 20719216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus vaccines: WHO position paper, May 2017.
    Wkly Epidemiol Rec; 2017 May; 92(19):241-68. PubMed ID: 28530369
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
    Gendel JE
    Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
    [No Abstract]   [Full Text] [Related]  

  • 19. [HPV and cervical cancer].
    J Midwifery Womens Health; 2013; 58(2):245-6. PubMed ID: 23451858
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticipating full benefits from the new papillomavirus vaccines.
    Griffiths PD
    Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.